16
Jan

Just days after Johnson & Johnson began a Phase I study of its new Ebola vaccine the pharma giant has organized an alliance to help accelerate its work and picked up a $116 million-plus grant to add to its $200 million commitment to get the job done as quickly as possible.

…read more

Source: J&J gets $116M to help hustle along new Ebola vaccine

    

0 No comments